Expression of vascular endothelial growth factor and its receptors in multiple myeloma and other hematopoietic malignancies

[1] Anderson KC, 1999, SEMIN HEMATOL, V36, P3

[2] MECHANISMS OF BONE DESTRUCTION IN MULTIPLE-MYELOMA - THE IMPORTANCE OF AN UNBALANCED PROCESS IN DETERMINING THE SEVERITY OF LYTIC BONE-DISEASE [J]. JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (12) : 1909 - 1914

[3] Multiple myeloma [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (23) : 1657 - 1664

[4] Bellamy W. T., 1999, Proceedings of the American Association for Cancer Research Annual Meeting, V40, P227

[5] Bellamy WT, 1999, CANCER RES, V59, P728

[6] Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes [J]. BLOOD, 2001, 97 (05) : 1427 - 1434

[7] Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (02) : 159 - 165

[8] BROWN LF, 1993, AM J PATHOL, V143, P1255

[9] Molecular biology of the VEGF and the VEGF receptor family [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2000, 26 (05) : 561 - 569

[10] Bone disease in multiple myeloma [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1998, 103 (04) : 902 - 910

[1] Anderson KC, 1999, SEMIN HEMATOL, V36, P3

[2] MECHANISMS OF BONE DESTRUCTION IN MULTIPLE-MYELOMA - THE IMPORTANCE OF AN UNBALANCED PROCESS IN DETERMINING THE SEVERITY OF LYTIC BONE-DISEASE [J]. JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (12) : 1909 - 1914

[3] Multiple myeloma [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (23) : 1657 - 1664

[4] Bellamy W. T., 1999, Proceedings of the American Association for Cancer Research Annual Meeting, V40, P227

[5] Bellamy WT, 1999, CANCER RES, V59, P728

[6] Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes [J]. BLOOD, 2001, 97 (05) : 1427 - 1434

[7] Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (02) : 159 - 165

[8] BROWN LF, 1993, AM J PATHOL, V143, P1255

[9] Molecular biology of the VEGF and the VEGF receptor family [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2000, 26 (05) : 561 - 569

[10] Bone disease in multiple myeloma [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1998, 103 (04) : 902 - 910